Biotech Values

[DewDiligence]

MNTA Major Shareholders

[Updated for Oppenheimer filing.]


The table below shows all shareholders who file Form 13G and
all insiders with a 1%+ stake. The percentages in the table are
based on 49.1M diluted shares (#msg-42163809), and hence they
differ from the percentages shown in SEC filings. Insider holdings
include restricted stock and options, whether or not vested.

 
                             Shares   Stake 
 Oppenheimer               5,003,200† 10.2% 
 Novartis                  4,708,679   9.6% 
 T Rowe Price              4,520,273   9.2% 
 BlackRock Inc.            2,782,260   5.7% 
 Visium Asset Mgmt         2,307,096   4.7% 
 Samana Capital            2,048,303   4.2% 
 Craig Wheeler (CEO)       1,145,469   2.4% 
 G. Venkataraman (SVP)       631,315   1.3%  
 R. Sasisekharan (Director)  507,344   1.0%

†As of 8/31/10 (from 13G filing 9/8/10).